SPARK A Mobile App to Help Women with Gestational Diabetes Manage Their Diet, Activity, and Blood Sugar
Led by Karolinska Institutet · Updated on 2026-08-10
360
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Gestational diabetes mellitus GDM is a growing health challenge, and this trial evaluates whether a new mobile health platform called SPARK can help women with GDM improve their self-management and prevent negative outcomes for both mother and baby. The study is a multi-center randomized controlled trial recruiting women diagnosed with GDM in South Eastern Sweden to compare SPARK plus standard care against standard care alone.
Participants in the intervention group will use the SPARK app, which supports healthier eating, increased physical activity, and daily blood glucose monitoring. All participants will receive standard care for GDM, while the intervention group receives additional support through the digital platform. The study measures outcomes during pregnancy and up to one year after delivery.
Women will be monitored for glucose control, diet quality, physical activity, metabolic and inflammatory markers, and pregnancy outcomes such as pre-eclampsia and delivery complications. Follow-up includes assessments of cardiometabolic risk and lifestyle behaviors one year postpartum. The study tracks blood glucose variability and infant health measures to understand the impact of the SPARK platform on managing GDM.
CONDITIONS
Brief Title
SPARK- a Digital Platform to Improve Self-management of Gestational Diabetes
Research Team
M
Marie Löf, Professor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
A confirmed diagnosis of gestational diabetes mellitus detected by oral glucose tolerance test as per World Health Organization guidelines
Female participants
Age between 18 and 50 years
You will not qualify if you...
Known diabetes diagnosed before this pregnancy
Twin pregnancy
Under 18 years of age
Severe co-morbidities limiting participation or severe psychiatric illness previously diagnosed
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - From diagnosis until delivery (approximately 3 to 4 months)
Participants in the intervention group will use the SPARK app for support with diet, physical activity, and blood glucose monitoring, while all participants receive standard care for gestational diabetes.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Comparing Oral Metformin and Injectable Insulin Treatments for Gestational Diabetes Mellitus in Pregnancy
Study of Gestational Diabetes Mellitus and Its Effects on Mothers and Their Children
Tracking Pregnancy and Long-Term Health Outcomes
Study on the Two-Way Relationship Between Gestational Diabetes and Perinatal Depression with a Health Education Program
Evaluating Home Ultrasound in Telemedicine Care for Women with Gestational Diabetes Mellitus Comparing Patient Satisfaction and Pregnancy Outcomes
Study on How Timing and Quality of Eating During Pregnancy Affect Gestational Diabetes and Weight Gain
Understanding Pancreas Function During and After Pregnancy in Women With Gestational Diabetes Mellitus Using Exendin 9-39 Infusion
Effects of Different Exercise Types and Intensities on Blood Sugar Control in Pregnant Women with Gestational Diabetes
Study of New Biomarkers for Prediabetes and Diabetes Using MALDI-TOF MS Technology
Including Pregnant and Non-Pregnant Participants
SPARK A Mobile App to Help Women with Gestational Diabetes Manage Their Diet, Activity, and Blood Sugar
A Study Testing Strawberry Candy Twists as a New Way to Screen for Gestational Diabetes
Comparing Candy to the Standard Glucola Beverage in Pregnant Women
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
SPARK: an mHealth intervention for self-management and treatment of gestational diabetes mellitus in Sweden - protocol for a randomised controlled trial.